These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6199554)

  • 1. [Quantitative immunoenzyme method for determining fibrin-fibrinogen degradation products in the blood].
    Ermolin GA; Liusov VA; Panchenko EP
    Lab Delo; 1984; (1):11-5. PubMed ID: 6199554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
    Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of fibrin-fibrinogen degradation products in the blood serum by an immunological method].
    Andreenko GV; Liutova LB
    Lab Delo; 1976; (4):206-8. PubMed ID: 66370
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantification of the fibrinogen degradation products FDP-D and FDP-E in blood, using immunoenzyme analysis].
    León VJ; León E; López Borrasca A
    Sangre (Barc); 1986; 31(1):23-30. PubMed ID: 3085242
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative determination of fibrinogen and fibrin degradation products by means of immunodiffusion].
    Paradeeva IK; Zhukova IV
    Lab Delo; 1979; (10):590-2. PubMed ID: 94124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of Soviet immunoenzyme test systems for the quantitative determination of myoglobin, fibrinogen and fibrin-fibrinogen degradation products].
    Shelepova TM; Ermolin GA; Osmanov SK; Dikov MM; Efremov EE
    Lab Delo; 1988; (3):72-3. PubMed ID: 2453730
    [No Abstract]   [Full Text] [Related]  

  • 7. [An immunonephelometric micromethod of determining the levels of fibrin-fibrinogen degradation products].
    Ivanov EP; Tsvirko DG
    Lab Delo; 1989; (10):12-5. PubMed ID: 2481061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemical method of determining fibrin (fibrinogen) degradation products using the method of Nannig and Guest].
    Andreenko GV; Podorol'skaia LV
    Probl Gematol Pereliv Krovi; 1976 Oct; 21(10):49-50. PubMed ID: 1005378
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinogen degradation products].
    Yoshino G; Mori T; Urayama T
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():370-5. PubMed ID: 9513445
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoenzyme histochemical localization of fibrin degradation products in tissues.
    Emeis JJ; Lindeman J; Nieuwenhuizen W
    Am J Pathol; 1981 Jun; 103(3):337-44. PubMed ID: 7015871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the hemorheological factors in ischemic heart disease and cerebrovascular disorders.
    Fukuda I; Yoshida T; Yoritsune H; Kiso T; Konishi S; Kawasaki T; Mozai T
    Bull Osaka Med Sch; 1978 Oct; 24(2):83-91. PubMed ID: 757138
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrin/fibrinogen degradation products in ischemic heart disease].
    Ena IaM; Polishko VK; Semina AG
    Vrach Delo; 1989 May; (5):9-14. PubMed ID: 2672587
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoenzyme determination of fibrinogen and its degradation products in kidney diseases].
    Maĭdannik VG
    Vrach Delo; 1989 May; (5):75-7. PubMed ID: 2672585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of FDP].
    Ikematsu S; Kuroso K
    Rinsho Byori; 1985 Feb; Spec No 61():86-96. PubMed ID: 3889425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of fibrinogen degradation products by rocket immunoelectrophoresis].
    Zozuliakova SV; Podosinnikov IS
    Lab Delo; 1981; (7):409-11. PubMed ID: 6167774
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Quantitative determination of fibrinogen-fibrin degradation products by viro-immunoassay.
    Lederman S; Rimon A
    Isr J Med Sci; 1975 Dec; 11(12):1395. PubMed ID: 1218992
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of fibrinogen, fibrin-monomer complexes, fibrin-fibrinogen degradation products and plasminogen levels in the capillary blood].
    Makarov VA; Rogacheva NA; Shelepova TM; Mamochkina EN; Ignashenkova GV; Ermolin GA; Belozerskaia GG
    Gematol Transfuziol; 1990 Jun; 35(6):33-4. PubMed ID: 2203668
    [No Abstract]   [Full Text] [Related]  

  • 19. GPR-phoresis, a novel approach to determining fibrin monomer and other macromolecular derivatives of fibrinogen and fibrin in blood.
    Shainoff JR; Urbanic DA; DiBello PM; Valenzuela V
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):87-92. PubMed ID: 8457658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.